Emtricitabine And Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 59651-166

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 59651-166). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (100 mg/150 mg (30 Tablets Bottle))

This is prescription drug information for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, with each tablet containing 100 mg of Emtricitabine and 150 mg of Tenofovir Disoproxil Fumarate. The medication guide is to be provided separately for each patient by the pharmacist. The recommended dosage is to be determined by a healthcare provider. Store the tablets at controlled room temperature and keep them away from tampering.*

FDA Label Image

Package Label-principal Display Panel (133 mg/200 mg (30 Tablets Bottle))

This is a medication containing Emtricitabine and Tenofovir Disoproxil Fumarate Tablets. It is used under prescription, and comes in a pack of 30 film-coated pills. The usual dosage is specified in the package inset. The pills should be stored between 68°F to 77°F and dispensed in the original container only. Aurobindo Pharma USA Inc. distributed the medicine, which was manufactured in India. Additional details about its use are available in the Medication Guide provided separately to each patient. The text also indicates that there is a printing zone and a coding area on the container, with instructions not to print on the dotted lines in the zone.*

FDA Label Image

Package Label-principal Display Panel (167 mg/250 mg (30 Tablets Bottle))

This is a description of a prescription medication with the NDC code 59651-167-30. The medication is a tablet containing emtricitabine and tenofovir disoproxil fumarate, with each tablet containing 167mg of emtricitabine and 250mg of tenofovir disoproxil fumarate. The medication guide should be provided separately to each patient by the pharmacist. Dosage and administration instructions are included in the package insert. The medication should be stored at a temperature between 20° C and 25° C and in the original container. This medication is made in India and distributed by Aurobindo Pharma USA, Inc.*

FDA Label Image

Structure1 (Emtriteno Str1)

FDA Label Image

Structure2 (Emtriteno Str2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.